The Association of Anxiety and Depression with the Quality of Life of Inflammatory Bowel Disease Patients
), Marcellus Simadibrata K(2), Hamzah Shatri(3), Murdani Abdullah(4),
(1) Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
(2) Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
(3) Division of Psychosomatic and Palliative Care, Department of Internal Medicine, Faculty of Medicine, University of Indonesia/ Dr. Cipto Mangunkusumo National Central General Hospital, Jakarta
(4) Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
Corresponding Author
Abstract
Background: Inflammatory Bowel Disease (IBD), which is chronic and often recurrent, causes psychological changes in patients. This puts IBD patients at a higher risk of developing various mental disorders, especially anxiety and depression. IBD patients who had symptoms of anxiety or depression tended to show a lower quality of life than patients without those symptoms.
Methods: This research uses a cross-sectional design. Data collection was carried out using primary data obtained through interviews with IBD patients who were undergoing outpatient treatment from October to December 2023. Anxiety and depression were measured using the Hospital Anxiety Depression Scale (HADS) and quality of life for IBD patients was measured using the Inflammatory Bowel Disease Questionnaire 9 (IBDQ-9). These questionnaires have been translated into Indonesian and validated. The research sample is an accessible population that has passed the inclusion and exclusion criteria using unpaired numerical analytical sample calculations. The sample used in this research was 172 subjects.
Results: In the multivariate analysis, after controlling for confounding variables, the fully adjusted prevalence ratio (PR) for anxiety symptoms was 1.182 (CI: 1.061–1.317, p = 0.002). Similarly, the fully adjusted PR for depression symptoms was 1.221 (CI: 1.075–1.386, p = 0.002).
Conclusion: Anxiety and depression are more strongly associated with a decline in the quality of life of IBD patients based on the IBDQ-9 after controlling for confounding variables.
Keywords: Anxiety, depression, IBD, quality of life
Keywords
References
Pasternak G, Aebisher D, Filip R, Bartusik-Aebisher D. Inflammatory bowel disease: clinical aspects. European Journal of Clinical and Experimental Medicine. 2019;16(4):341–5.
Burisch J, Jess T, Martinato M, Lakatos PL. The burden of inflammatory bowel disease in Europe. Journal of Crohn’s and Colitis. 2013;7(4):322-37.
Bannaga AS, Selinger CP. Inflammatory bowel disease and anxiety: Links, risks, and challenges faced. Clinical and Experimental Gastroenterology. 2015:111–7.
Navabi S, Gorrepati VS, Yadav S, Chintanaboina J, Maher S, Demuth P, et al. Influences and impact of Anxiety and Depression in the setting of inflammatory bowel disease. Inflamm Bowel Dis. 2018 Nov 1;24(11):2303–8.
World Health Organization (WHO). Depression and other common mental disorders: global health estimates. Geneva: WHO; 2017.
Zhang B, Wang HHE, Bai YM, Tsai SJ, Su TP, Chen TJ, et al. Bidirectional association between inflammatory bowel disease and depression among patients and their unaffected siblings. Journal of Gastroenterology and Hepatology. 2022 Jul 1;37(7):1307–15.
Gao X, Tang Y, Lei N, Luo Y, Chen P, Liang C, et al. Symptoms of anxiety/depression is associated with more aggressive inflammatory bowel disease. Sci Rep. 2021;11(1):1–8.
Peppas S, Pansieri C, Piovani D, Danese S, Peyrin-Biroulet L, Tsantes AG, et al. The brain-gut axis: psychological functioning and inflammatory bowel diseases. J Clin Med. 2021;10(3):1–22.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta psychiatrica scandinavica. 1983;67(6), 361-70.
Rudy M, Widyadharma IPE, Adnyana IMO. Reliability indonesian version of the hospital anxiety and depression scale (HADS) of stroke patients in sanglah general hospital denpasar. ResearchGate. 2015;2:1-23.
Casellas F, Alcalá MJ, Prieto L, Miró JRA, Malagelada JR. Assessment of the Influence of Disease Activity on the Quality of Life of Patients with Inflammatory Bowel Disease Using a Short Questionnaire. American Journal of Gastroenterology. 2004 Mar;99(3):457–61.
Esa DF, Shatri H, Rumende CM, Susilo A, Maulahela H, Fauzi A, et al. Validity and reliability of the Indonesian version of the 9-item Inflammatory Bowel Disease Questionnaire (IBDQ-9). Medical Journal of Indonesia. 2023 Des 1;32(3):168–72.
Avinir A, Dar S, Taler M, Taler M, Haj O, Gothelf D, Kopylov U, Horin SB, Domachevsky EM. Keeping it simple: mental health assessment in the Gastroenterology Departement - Using the Hospital Anxiety and Depression Scale (HADS) for IBD pastients in Israel. Therapeutic Advances in Gastroenterology. 2022;15:1-8
Van der Have M, van der Aalst KS, Kaptein AA, Leenders M, Siersema PD, Oldenburg B, et al. Determinants of health-related quality of life in Crohn’s disease: A systematic review and meta-analysis. Journal of Crohn’s and Colitis. 2014;8(2):93–106.
Iglesias M, Vázquez I, De Barreiro Acosta M, Figueiras A, Nieto L, Piñeiro M, et al. Calidad de vida en pacientes con enfermedad de Crohn en remisión. Revista Espanola de Enfermedades Digestivas. 2010;102(11):624–30.
Castillo-Cejas MD, Robles V, Borruel N, Torrejón A, Navarro E, Peláez A, et al. Questionnaires for measuring fatigue and its impact on health perception in inflammatory bowel disease. Revista Española de Enfermedades Digestivas. 2013 Mar;105(3):144–53.
Bastida G, Herrera-de Guise C, Algaba A, Ber Nieto Y, Soares JM, Robles V, et al. Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment. Nutrients. 2021 May 22;13(6):1770.
Zheng K, Zhang S, Wang C, Zhao W, Shen H. Health-Related Quality of Life in Chinese Patients with Mild and Moderately Active Ulcerative Colitis. PLoS One. 2015 Apr 27; 10(4):1–6.
García-Alanís M, Quiroz-Casian L, Castañeda-González H, Arguelles-Castro P, Toapanta-Yanchapaxi L, Chiquete-Anaya E, et al. Prevalence of mental disorder and impact on quality of life in inflammatory bowel disease. Gastroenterol Hepatol. 2021 Mar 1;44(3):206–13.
Yamamoto-Furusho JK, Bozada Gutiérrez KE, Sarmiento-Aguilar A, Fresán-Orellana A, Arguelles-Castro P, García-
Mitropoulou MA, Fradelos EC, Lee KY, Malli F, Tsaras K, Christodoulou NG, et al. Quality of Life in Patients With Inflammatory Bowel Disease: Importance of Psychological Symptoms. Cureus. 2022 Aug 28; 14(8):1–8.
Hu S, Chen Y, Chen Y, Wang C. Depression and anxiety disorders in patients with inflammatory bowel disease. Front Psychiatry. 2021;12:1–10.
Tomazoni EI, Benvegnú DM. Symptoms of anxiety and depression, and quality of life of patients with Crohn’s disease. Arq Gastroenterol. 2018 Apr 1;55(2):148–53.
Park SC, Jeen YT. The mental health state of quiescent inflammatory bowel disease patients. Gut and Liver. 2016;10(3):330–1.
Farbod Y, Popov J, Armstrong D, Halder S, Marshall JK, Tse F, et al. Reduction in Anxiety and Depression Scores Associated with Improvement in Quality of Life in Patients with Inflammatory Bowel Disease. J Can Assoc Gastroenterol. 2022 Feb 1;5(1):12–7.
Alanis M. Depression and Anxiety Disorders Impact in the Quality of Life of Patients with Inflammatory Bowel Disease. Psychiatry J. 2021 Oct 27;2021:1–7.
Slomp FM, Bara TS, Picharski GL, Cordeiro ML. Association of cigarette smoking with anxiety, depression, and suicidal ideation among Brazilian adolescents. Neuropsychiatr Dis Treat. 2019;15:2799–808.
Ho PYM, Hu W, Lee YY, Gao C, Tan YZ, Cheen HH, et al. Health-related quality of life of patients with inflammatory bowel disease in Singapore. Intest Res. 2019 Jan 1;17(1):107–18.
Rezaei S, Matin BK, Karyani AK, Woldemichael A, Khosravi F, Khosravipour M, Rezaeian S. Impact of Smoking on Health-Related Quality od Life : A General Population Survey in West Iran. Asian Pacific Journal of Cancer Prevention. 2017;18(11):3179-85.
Severs M, Mangen MJJ, van der Valk ME, Fidder HH, Dijkstra G, van der Have M, et al. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease. J Crohns Colitis. 2016 Sep 19;11(3):342–52.
Flensborg-Madsen T, Bay Von Scholten M, Flachs EM, Mortensen EL, Prescott E, Tolstrup JS. Tobacco smoking as a risk factor for depression. A 26-year population-based follow-up study. J Psychiatr Res. 2011 Feb;45(2):143–9.
Bähler C, Schoepfer AM, Vavricka SR, Brüngger B, Reich O. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland. Eur J Gastroenterol Hepatol. 2017;29(8):916–25.
García-Alanis M, Toapanta-Yanchapaxi L, Reyes-Velásquez A, Mancilla F, Pérez-Mayo I, Yamamoto-Furusho JK. The interrelation between anxiety and quality of life among patients with ulcerative colitis in remission. Gastroenterol Hepatol [Internet]. 2023;46(10):747–53. Available from: https://www.sciencedirect.com/science/article/pii/S0210570523000055
Suls J, Green PA, Boyd CM. Multimorbidity: Implications and directions for health psychology and behavioral medicine. Health Psychology. 2019 Sep;38(9):772–82.
van den Brink G, Stapersma L, Vlug LE, Rizopolous D, Bodelier AG, van Wering H, et al. Clinical disease activity is associated with anxiety and depressive symptoms in adolescents and young adults with inflammatory bowel disease. Aliment Pharmacol Ther. 2018 Aug 1;48(3):358–69.
Matos R, Lencastre L, Rocha V, Torres S, Vieira F, Barbosa MR, et al. Quality of life in patients with inflammatory bowel disease: the role of positive psychological factors. Health Psychol Behav Med. 2021;9(1):989–1005.
Article Metrics
Abstract View
: 74 times
Download : 33 times
DOI: 10.24871/261202519-27
Refbacks
- There are currently no refbacks.
